Investor Presentation Q1 2022

Use of proceeds from future capital raise avantium €45m plantMEG: Further develop plantMEG technology (technical validation, commercial & application validation) Scale-up towards further commercialization via technology licensing Other technologies: Further develop biorefinery and CO2 based chemicals and polymers technologies Assess economic feasibility & scale-up towards further commercialization Overall funding: Allowing positive cash balances for the following 3yrs Sufficient funding in conjunction with secured debt financing Avantium | Investor Presentation Q1 2022 33 33

View entire presentation